PDS Biotechnology Corp (FRA:EU6)
€ 2.814 0.028 (1.01%) Market Cap: 112.55 Mil Enterprise Value: 81.65 Mil PE Ratio: 0 PB Ratio: 3.92 GF Score: 37/100

PDS Biotechnology Corp Extraordinary Shareholders Meeting Transcript

Jan 19, 2022 / 02:00PM GMT
Release Date Price: €5.54 (-6.20%)
Frank Bedu;Addo
PDS Biotechnology Corp - President and CEO

Good morning. I am Frank Bedu-Addo, President and CEO. of PDS Biotechnology Corporation. Let me take this opportunity to welcome you to the special meeting of stockholders of PDS Biotechnology Corporation.

Due to continued public health concerns resulting from the COVID-19 pandemic and government recommended and required limits on public gatherings and to protect the health and safety of the company's stockholders, directors and employees, this special meeting is being held in a virtual-only meeting format. This allows stockholders regardless of physical location to participate in today's meeting. Not only can you listen to the meeting, but you can also submit questions and vote your shares online prior to the closing of the polls in accordance with the instructions you received prior to the meeting. The polls are now open.

The purpose of today's meeting is to consider the following proposal: to ratify the prior approval of the second amended and restated PDS Biotechnology Corporation 2014 Equity Incentive Plan

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot